Suppr超能文献

儿童慢性哮喘管理指南——2000年更新版。南非过敏协会工作组

Guideline for the management of chronic asthma in children--2000 update. Allergy Society of South Africa Working Group.

作者信息

Motala C, Kling S, Gie R, Potter P C, Manjra A, Vermeulen J, Weinberg E G, Green R

机构信息

Division of Allergy, University of Cape Town, Rondebosch.

出版信息

S Afr Med J. 2000 May;90(5 Pt 2):524-8, 530, 532 passim.

Abstract

OBJECTIVE

To increase awareness of asthma and diagnose asthma early in children. To make recommendations regarding management of chronic childhood asthma in a country with diverse cultural, socio-economic and educational characteristics. The guideline should be used by health professionals involved in the treatment of asthma at all levels of care.

OPTIONS

Various management options were considered. Ideal treatment includes use of the new generation inhaled corticosteroids (fluticasone, budesonide), housedust mite intervention for asthma control using impermeable covers for pillows and mattresses, and if needed use of inhaled long-acting beta 2 agonists (LABAs) and leukotriene receptor antagonists (LRAs). Alternative therapeutic approaches for situations where resources are limited include simple housedust mite control measures (e.g. airing mattresses and bedding), avoidance of exposure to passive smoking, use of lower doses of beclomethasone than recommended by other guideline documents and/or sustained-release (SR) theophylline as preventer treatment and use of plastic bottles as cheap spacer devices.

OUTCOMES

The main potential outcomes considered were: to reduce morbidity and mortality by correct diagnosis of asthma, to achieve the best quality of life for the child with asthma, to minimise side-effects from medication and to prevent development of permanently abnormal lung function.

EVIDENCE

Current international guideline documents for diagnosis and management of childhood asthma were evaluated. Clinical studies before 1998 pertaining to the various aspects of management of childhood asthma were reviewed, including controlled studies on the use of inhaled corticosteroids in children with asthma, randomised controlled trials on the use of LRAs and two studies evaluating the efficacy of LABAs. Current data on the anti-inflammatory effects of SR theophylline were also reviewed as well as a randomised controlled trial on the benefits of SR theophylline as adjunct treatment in childhood asthma. The benefit of simple spacer devices, based on well-conducted local studies (published in an international peer-reviewed journal) was also considered.

VALUES

The South African Childhood Asthma Working Group (SACAWG) committee members, appointed by the Allergy Society of South Africa (ALLSA), were selected to represent the interests of health professionals involved in the care of childhood asthma and to co-opt other colleagues with expertise relevant to the guideline. The committee was divided into six task groups headed by a chairperson--each task group had to review critically the previous SACAWG guideline (for deficiencies and obstacles to implementation), review current trends in asthma management (evidence-based where available) and submit proposals and recommendations to their respective chairperson. The chairperson then compiled a report for discussion by the SACAWG executive committee. The executive group convened a meeting to discuss the recommendations and obtain consensus. An editorial board was appointed to compile the final report. Cultural factors, patient preferences, cost, availability and education were considered important.

BENEFITS, HARMS AND COSTS: Proper treatment should enable most children with asthma to lead normal or near-normal lives. The guideline could be implementable at all levels of care. The risk of systemic effects due to inhaled corticosteroids should be minimised in children with mild to moderate persistent asthma (risk of systemic effects is more likely at daily beclomethasone doses exceeding 400 micrograms or the equivalent dose of other inhaled corticosteroids). Promotion of simple environmental control measures and use of inhaled beclomethasone and/or SR theophylline should make treatment more widely available and more affordable and improve adherence to treatment. Alternative cheap plastic bottle spacer devices will increase availability and assist with overcoming the problem of incorrect inha

摘要

目的

提高对哮喘的认识并在儿童中早期诊断哮喘。针对一个具有多元文化、社会经济和教育特点的国家中儿童慢性哮喘的管理提出建议。该指南应由各级护理中参与哮喘治疗的卫生专业人员使用。

选项

考虑了各种管理选项。理想的治疗方法包括使用新一代吸入性糖皮质激素(氟替卡松、布地奈德),使用枕头和床垫的不透水罩进行屋尘螨干预以控制哮喘,以及在需要时使用吸入长效β2受体激动剂(LABAs)和白三烯受体拮抗剂(LRAs)。资源有限情况下的替代治疗方法包括简单的屋尘螨控制措施(如晾晒床垫和床上用品)、避免接触二手烟、使用比其他指南文件推荐剂量更低的倍氯米松和/或缓释(SR)茶碱作为预防治疗,以及使用塑料瓶作为廉价的储雾罐装置。

结果

考虑的主要潜在结果为:通过正确诊断哮喘降低发病率和死亡率,为哮喘儿童实现最佳生活质量,将药物副作用降至最低,并预防永久性异常肺功能的发展。

证据

评估了当前关于儿童哮喘诊断和管理的国际指南文件。回顾了1998年以前关于儿童哮喘管理各个方面的临床研究,包括哮喘儿童使用吸入性糖皮质激素的对照研究、使用LRAs的随机对照试验以及两项评估LABAs疗效的研究。还回顾了SR茶碱抗炎作用的当前数据以及一项关于SR茶碱作为儿童哮喘辅助治疗益处的随机对照试验。基于开展良好的本地研究(发表在国际同行评审期刊上),也考虑了简单储雾罐装置的益处。

价值观

由南非过敏学会(ALLSA)任命的南非儿童哮喘工作组(SACAWG)委员会成员被挑选出来,以代表参与儿童哮喘护理的卫生专业人员的利益,并吸纳其他具有与该指南相关专业知识的同事。委员会分为六个任务组,由一名主席领导——每个任务组必须严格审查先前的SACAWG指南(查找实施中的缺陷和障碍),审查哮喘管理的当前趋势(如有可用的循证依据),并向各自的主席提交提案和建议。然后主席编写一份报告供SACAWG执行委员会讨论。执行小组召开会议讨论这些建议并达成共识。任命了一个编辑委员会来编写最终报告。文化因素、患者偏好、成本、可及性和教育被视为重要因素。

益处、危害和成本:适当的治疗应使大多数哮喘儿童能够过上正常或接近正常的生活。该指南应能在各级护理中实施。对于轻度至中度持续性哮喘儿童,应将吸入性糖皮质激素引起全身效应的风险降至最低(当每日倍氯米松剂量超过400微克或其他吸入性糖皮质激素的等效剂量时,更有可能出现全身效应风险)。推广简单的环境控制措施以及使用吸入性倍氯米松和/或SR茶碱应使治疗更广泛可得且更经济实惠,并提高治疗依从性。替代的廉价塑料瓶储雾罐装置将增加可及性,并有助于克服吸入不正确的问题。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验